Compounds > medroxyprogesterone acetate
Page last updated: 2024-08-17

medroxyprogesterone acetate and Candidiasis, Genital

medroxyprogesterone acetate has been researched along with Candidiasis, Genital in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, S; Brill, I; Chomba, E; Haddad, LB; Kilembe, W; Sharkey, T; Tichacek, A; Tote, K; Vwailika, B; Wall, KM1
Morrison, CS; Turner, AN; van de Wijgert, JH; Verwijs, MC1
Buchta, V; Jílek, P; Kestřánek, J; Leško, D; Plucnarová, S; Špaček, J1
Dennerstein, G1
Johnson, EM; Warnock, DW; White, DJ1
Jackson, DJ; Kreiss, J; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA1
Baeten, JM; Bwayo, JJ; Chohan, B; Kreiss, JK; Lavreys, L; Mandaliya, K; Martin, HL; Ndinya-Achola, JO; Nyange, PM; Richardson, BA1
Presl, J1

Reviews

1 review(s) available for medroxyprogesterone acetate and Candidiasis, Genital

ArticleYear
Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission.
    AIDS (London, England), 2013, Aug-24, Volume: 27, Issue:13

    Topics: Candidiasis, Vulvovaginal; Contraception; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Risk Assessment; Vaginosis, Bacterial

2013

Other Studies

7 other study(ies) available for medroxyprogesterone acetate and Candidiasis, Genital

ArticleYear
Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.
    Obstetrics and gynecology, 2019, Volume: 134, Issue:3

    Topics: Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral, Hormonal; Female; HIV Seronegativity; HIV Seropositivity; Hormonal Contraception; Humans; Male; Medroxyprogesterone Acetate; Sexual Partners; Trichomonas Vaginitis; Vaginitis; Vaginosis, Bacterial; Zambia

2019
Comparison of two long-term gestagen regimens in the management of recurrent vulvovaginal candidiasis: A pilot study.
    Mycoses, 2017, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Disease Management; Female; Humans; Medroxyprogesterone Acetate; Pilot Projects; Progestins; Prospective Studies; Quality of Life; Recurrence; Time; Visual Analog Scale; Young Adult

2017
Vaginal yeast colonization in nonpregnant women: a longitudinal study.
    Obstetrics and gynecology, 2005, Volume: 105, Issue:6

    Topics: Candida albicans; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Vagina

2005
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
    Genitourinary medicine, 1993, Volume: 69, Issue:2

    Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin

1993
Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:4

    Topics: Behavior; Candidiasis, Vulvovaginal; Contraception; Contraceptive Agents, Female; Contraceptive Devices; Demography; Female; HIV Seropositivity; HIV-1; Humans; Kenya; Medroxyprogesterone Acetate; Multivariate Analysis; Prospective Studies; Risk Factors; Sex Work; Sexually Transmitted Diseases; Ulcer; Vaginal Discharge; Vulvitis

1998
Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    American journal of obstetrics and gynecology, 2001, Volume: 185, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Candidiasis, Vulvovaginal; Chlamydia Infections; Cohort Studies; Condoms; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonorrhea; Humans; Kenya; Medroxyprogesterone Acetate; Middle Aged; Pelvic Inflammatory Disease; Prospective Studies; Risk Factors; Sex Work; Sexual Behavior; Sexually Transmitted Diseases; Trichomonas Vaginitis; Vaginosis, Bacterial

2001
[Medroxyprogesterone acetate in the treatment of recurrent vaginal candidiasis].
    Ceskoslovenska gynekologie, 1988, Volume: 53, Issue:7

    Topics: Candidiasis, Vulvovaginal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Recurrence

1988